Immunopathogenesis of Sjogren's syndrome

被引:51
作者
Borchers, AT
Naguwa, SM
Keen, CL
Gershwin, ME
机构
[1] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Sch Med, Davis, CA 95616 USA
[2] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA
关键词
Sjogren's syndrome; autoimmune disease; autoantigens; cytokines; apoptosis;
D O I
10.1385/CRIAI:25:1:89
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Sjogren's syndrome (SS) is an autoimmune disease characterized by the sicca symptoms of dry eyes and dry mouth. Glandular dysfunction is thought to arise from destruction associated with lymphocytic infiltration. The degree of glandular destruction, however, does not correlate with the severity of sicca symptoms, suggesting that other mechanisms are involved, including abnormalities in parasympathetic neurotransmission. Autoantibodies against the muscarinic acetylcholine receptor have been implicated in this process, but multiple other autoantibodies have been found. Cytokines elaborated in the inflammatory lesions also appear to be involved and dysregulation of apoptosis are also involved in the pathogenesis of SS. A new two-stage model of SS has been proposed. First, there is a lymphocyte-independent phase during which inappropriate apoptosis results in the generation of apoptotic autoantigens which then attract lymphocytes. Subsequently, in the second lymphocyte-dependent phase, an immune attack causes further cell death and salivary dysfunction. Although the disease I generally takes a rather stable and benign course, patients with SS have a significant risk of developing B cell lymphoma.
引用
收藏
页码:89 / 104
页数:16
相关论文
共 121 条
[1]  
Ajjan RA, 1998, BRIT J RHEUMATOL, V37, P179
[2]   EXPRESSION OF GRANZYME-A IN SALIVARY-GLAND BIOPSIES FROM PATIENTS WITH PRIMARY SJOGRENS-SYNDROME [J].
ALPERT, S ;
KANG, HI ;
WEISSMAN, I ;
FOX, RI .
ARTHRITIS AND RHEUMATISM, 1994, 37 (07) :1046-1054
[3]   Chemokines and cell trafficking in Sjogren's syndrome [J].
Amft, N ;
Bowman, SJ .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 54 (1-2) :62-69
[4]   TAP, HLA-DQB1, and HLA-DRB1 polymorphism in Colombian patients with primary Sjogren's syndrome [J].
Anaya, JM ;
Correa, PA ;
Mantilla, RD ;
Arcos-Burgos, M .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2002, 31 (06) :396-405
[5]  
Bacman S, 1998, INVEST OPHTH VIS SCI, V39, P151
[6]   Circulating antibodies against rat parotid gland M(3) muscarinic receptors in primary Sjogren's syndrome [J].
Bacman, S ;
SterinBorda, L ;
Camusso, JJ ;
Arana, R ;
Hubscher, O ;
Borda, E .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (03) :454-459
[7]  
Bacman S, 2001, INVEST OPHTH VIS SCI, V42, P321
[8]   Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjogren's syndrome) begin as nonmalignant antigen-selected expansions [J].
Bahler, DW ;
Swerdlow, SH .
BLOOD, 1998, 91 (06) :1864-1872
[9]   Up-regulation of M3-muscarinic receptors in labial salivary gland acini in primary Sjogren's syndrome [J].
Beroukas, D ;
Goodfellow, R ;
Hiscock, J ;
Jonsson, R ;
Gordon, TP ;
Waterman, SA .
LABORATORY INVESTIGATION, 2002, 82 (02) :203-210
[10]   Role of salivary IgA in the pathogenesis of Sjogren syndrome [J].
Berra, A ;
Sterin-Borda, L ;
Bacman, S ;
Borda, E .
CLINICAL IMMUNOLOGY, 2002, 104 (01) :49-57